Your browser doesn't support javascript.
loading
Differences in the treatment needs of patients with dementia with Lewy bodies and their caregivers and differences in their physicians' awareness of those treatment needs according to the clinical department visited by the patients: a subanalysis of an observational survey study.
Ikeda, Manabu; Toya, Shunji; Manabe, Yuta; Yamakage, Hajime; Hashimoto, Mamoru.
Afiliación
  • Ikeda M; Department of Psychiatry, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-Shi, Osaka, 565-0871, Japan. mikeda@psy.med.osaka-u.ac.jp.
  • Toya S; Medical Science, Sumitomo Pharma Co., Ltd., Chuo-Ku, Tokyo, Japan.
  • Manabe Y; Department of Advanced Clinical Medicine, Division of Dementia and Geriatric Medicine, Kanagawa Dental University School of Dentistry, Yokosuka, Japan.
  • Yamakage H; Insight Clinical Development Group, 3H Medi Solution Inc., Toshima-Ku, Tokyo, Japan.
  • Hashimoto M; Department of Psychiatry, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-Shi, Osaka, 565-0871, Japan.
Alzheimers Res Ther ; 16(1): 59, 2024 03 14.
Article en En | MEDLINE | ID: mdl-38481342
ABSTRACT

BACKGROUND:

We investigated whether the treatment needs of patients with dementia with Lewy bodies (DLB) and their caregivers, along with their attending physicians' perception of those treatment needs, differ according to the clinical department visited by the patients.

METHODS:

This was a subanalysis of a multicenter, cross-sectional, observational survey study. Data from the main study were classified according to the clinical department visited by the patient psychiatric group (P-group), geriatric internal medicine group (G-group), and neurology group (N-group). The treatment needs of patients and caregivers were defined as "the symptom that causes them the most distress", and the frequency of each answer was tabulated.

RESULTS:

This subanalysis included 134, 65, and 49 patient-caregiver pairs in the P-, G-, and N-groups, respectively. Statistically significant differences in patient background characteristics such as patient age; initial symptom domains; use of cholinesterase inhibitors, levodopa, antipsychotics, and Yokukansan; and total scores of the Mini-Mental State Examination, Neuropsychiatric Inventory-12, and Movement Disorder Society-Unified Parkinson's Disease Rating Scale Parts II and III were shown among the three subgroups. While there were no differences in patients' treatment needs among the subgroups, residual analysis showed that in the N-group, parkinsonism was more of a problem than other symptom domains (p = 0.001). There were significant differences in caregivers' treatment needs among the three subgroups (p < 0.001). The patient-physician concordance rates for the symptom domains that caused patients the most distress were P-group, 42.9% (kappa coefficient [κ] = 0.264); G-group, 33.3% (κ = 0.135), and N-group, 67.6% (κ = 0.484). The caregiver-physician concordance rates for the symptom domains that caused the caregivers the most distress were P-group, 54.8% (κ = 0.351), G-group, 50.0% (κ = 0.244), and N-group, 47.4% (κ = 0.170).

CONCLUSION:

This subanalysis revealed differences in the treatment needs of patients with DLB and their caregivers according to the clinical department they attended. There might be a lack of awareness of those treatment needs by the attending physicians, regardless of their specialty. TRIAL REGISTRATION UMIN Clinical Trials Registry UMIN000041844.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Médicos / Enfermedad por Cuerpos de Lewy Idioma: En Revista: Alzheimers Res Ther Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Médicos / Enfermedad por Cuerpos de Lewy Idioma: En Revista: Alzheimers Res Ther Año: 2024 Tipo del documento: Article